0.3 µM nilotinib-resistant KCL-22
Homo sapiens
source_name
Blood (chronic myeloid leukemia in blast crisis)
cell line
CML cell line KCL-22
treatment
ClonTracer-barcoded KCL-22 cell population was treated with 0.3 µM nilotinib for 27 days to acquire nilotinib-resistant cell population.
resistant to
0.3 µM nilotinib